APA (7th ed.) Citation

Epstein, D. J. (2026). COUNTERPOINT: Is Monitoring Drug Levels Clinically Useful in the Management of Patients With Nontuberculous Mycobacterial Lung Disease? No. CHEST, 170(2), 315. https://doi.org/10.1016/j.chest.2026.02.048

Chicago Style (17th ed.) Citation

Epstein, David J. "COUNTERPOINT: Is Monitoring Drug Levels Clinically Useful in the Management of Patients With Nontuberculous Mycobacterial Lung Disease? No." CHEST 170, no. 2 (2026): 315. https://doi.org/10.1016/j.chest.2026.02.048.

MLA (9th ed.) Citation

Epstein, David J. "COUNTERPOINT: Is Monitoring Drug Levels Clinically Useful in the Management of Patients With Nontuberculous Mycobacterial Lung Disease? No." CHEST, vol. 170, no. 2, 2026, p. 315, https://doi.org/10.1016/j.chest.2026.02.048.